Dudediligence.

Silexion Therapeutics Corp

SLXNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$11.9MSep ’24−$1.7MDec ’24−$1.7MMar ’25−$2.5MJun ’25−$3.3MSep ’25−$4.4MDec ’25−$2.7MMar ’26−$3.6MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$4.7M−$12.6M−$11.6M
Net incomenone on file−$5.1M−$16.5M−$11.9M
Operating cash flownone on file−$4.5M−$8.4M−$10.8M
Free cash flownone on file−$4.5M−$8.4M−$10.8M
Cash$8.3M$4.6M$1.2M$6.0M
Shares outstandingnone on file97.1M123.3M3.13B